Company Sangui Biotech International, Inc.
Equities
SBH
US80105B1017
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 EUR | -20.00% | -.--% | -33.33% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 05-02-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 05-02-06 |
Hubertus Schmelz
BRD | Director/Board Member | 68 | 08-12-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 209,955,598 | 182,538,524 ( 86.94 %) | 53,756 ( 0.0256 %) | 86.94 % |
Company contact information
Sangui BioTech International, Inc.
Bleichenbruecke 9
20354, Hamburg
+49 40 609 3120
http://www.sanguibiotech.comSector
1st Jan change | Capi. | |
---|---|---|
-33.33% | 448K | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- SBH Stock
- Company Sangui Biotech International, Inc.